Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of UBT251 in overweight or obese adults
CTR20250288Phase 2Completed
- Sponsor
- The United Laboratories International Holdings
- Start
- Feb 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of UBT251 in obesity, Overweight, sponsored by The United Laboratories International Holdings. Started Feb 2025; status: completed.
02
Drugs
UBT251
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20250288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250288.